Received Feb 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4777F | — |
only been administered with the saline solution; only been administered with the saline solution; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in an unspecified number of patients who received Hib (Hiberix) (batch number 4777F, expiry date 17-MAR-2026) for prophylaxis. On an unknown date, the patient received Hiberix. On an unknown date, an unknown time after receiving Hiberix, the patient experienced inappropriate preparation of medication (Verbatim: only been administered with the saline solution) and inappropriate dose of vaccine administered (Verbatim: only been administered with the saline solution). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 09-JAN-2025 Reporter stated that six different patients received a Hiberix vaccine and two of them had only been administered with the saline solution. Reporter did not know which were the two patients that received the full dose. Vaccination date was asked, nevertheless the reporter mentioned it occurred between September and December of last year (twenty-twenty four). They asked about any concerning information regarding safety, or if they have to readminister those two doses. No patient demographics were provided and no further information was provided. The patients received only saline solution of Hiberix which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.